Correlation between serum pepsinogen levels and gastric mucosal histological findings before and after Helicobacter pylori eradication therapy

Digestive Endoscopy

Volumn 16, Issue 2, 2004, Pages 122-128

  Kawai, Takashi ^a,b   Kawakami, Kohei ^a   Kudo, Taku ^a   Takei, Kazuo ^a   Moriyasu, Fuminori ^a   Takagi, Yuu ^c   Aoki, Tatsuya ^c   Koyanagi, Yasuhisa ^c   Serizawa, Hiromi ^b   Rinbara, Emiko ^a   Noguchi, Masahisa ^a   Sasatsu, Masanori ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Atrophy; Eradication; Helicobacter pylori; Pepsinogen; Topography

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; OMEPRAZOLE; PEPSINOGEN; RABEPRAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CHRONIC GASTRITIS; CONSTIPATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DIARRHEA; ENZYME BLOOD LEVEL; ERADICATION THERAPY; EYELID EDEMA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OTOTOXICITY; RASH; STOMACH BIOPSY; STOMACH MUCOSA;

EID: 2442421058     PISSN: 09155635     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1443-1661.2003.00324.x     Document Type: Article

References (30)

1. Marshal GJ, Warren JR. Unidentified curve bacilli in the stomach of patient with gastritis and peptic ulceration. Lancet 1984; I: 1311-14.
2. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumi K, Kajiyama G. Helicobacter pylori infection infection is the major risk factor for atrophic gastritis. Am. J. Gastroenterol. 1996; 91: 959-62.
3. Kuipers EJ, Uyterlinde AM, Pena AS et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1425-528.
4. Nomura A, Stemmermann GN, Chyou PH et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Eng. J. Med. 1991; 325: 1132-6.
5. Haruma K, Komoto K, Kamada T et al. Helicobacter pylori is a major risk factor for gastric carcinoma in young patients. Scand. J. Gastroenterol. 2000; 35: 255-9.
6. Wotherspoon AC, Doglioni C, de Boni M, Spencer J, Isaacson PG. Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet 1994; 343: 1503.
7. Parsonnet J, Friedman GD, Vanersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Eng. J. Med. 1991; 325: 1127-31.
8. Komoto K, Haruma K, Kamada T et al. Helicobactor pylori infection and gastric neoplasia: correlation with histological gastritis and tumor histology. Am. J. Gastroenterol. 1998; 93: 1271-6.
9. Correa P. Human gastric carcinogenesis: a multistep multifactorial process. First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res. 1992; 52: 6735-40.
10. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Eng. J. Med., 2001; 345: 784-9.
11. Ohkusa Y, Fujiki K, Takashimizu I et al. Improvement in atrophic gastritis and intestinal metaplasia in patients with Helicobacter pylori. Ann. Int. Med. 2001; 134: 380-6.
12. Satoh K, Kimura K, Takimoto T, Kihira K. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998; 3: 236-40.
13. Ito M, Haruma K, Kamada T et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment. Pharmacol. Ther. 2002; 16: 1449-56.
14. Annibale B, Giulio EDI, Caruana R. et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment. Pharmacol. Ther. 2002; 16: 1823-31.
15. Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurosawa A, Sato N. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2002; 16: 1923-32.
16. Hahm KB, Lee KJ, Choi SY et al. Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection. Am. J. Gastroenterol. 1997; 92: 1853-7.
17. Uemura N, Mukai T, Okamoto S et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol. Biomarkers Prev. 1997; 6: 639-42.
18. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 1982; 83: 204-9.
19. Miki K, Ichinose M, Shimizu A et al. Serum pepsinogens as a screening test of extensive cronic gastristis. Gastroenterol. Jpn 1987; 22: 133-41.
20. Miki K, Ichinose M, Ishikawa KB et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn. J. Cancer Res. 1993; 10: 1086-90.
21. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am. J. Gastroenterol. 2003; 98: 735-9.
22. Kodoi A, Yoshihara M, Sumi K, Haruma K, Kajiyama G. Serum pepsinogen in screening for gastric cancer. J. Gastroenterol. 1995; 30: 452-60.
23. Asaka M, Kimura T, Kudo M et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760-6.
24. Bodger K, Wyatt JI, Heatly RV. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy. Helicobacter 2001; 6: 216-24.
25. Sipponen P, Ranta P, Helske T et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis; an observational case-control study. Scand. J. Gastroenterol. 2002; 37: 785-91.
26. Broutete N, Pelbani M, Sakarovitch C et al. Pepesinogen A, pepsinogen C and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br. J. Can. 2003; 88: 1239-47.
27. Knight T, Greaves S, Wilson A, Hengels K et al. Variability in serum pepsinogen levels in an asymptomatic population. Eur J. Gastroenterol. Hepatol. 1995; 7: 647-54.
28. Cave TR, Cave DR. Helicobacter pylori stimulating pepsin secretion from isolated rabbit gastric glands. Scand. J Gastroenterol. 1991; 26: 9-14.
29. Wagner S, Haruma K, Gladziwa U et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am. J. Gastroenterol. 1994; 89: 1211-18.
30. Furuta T, Kaneko E, Baba S, Arai H, Futami H. Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori. Am. J. Gastroenterol. 1997; 92: 84-8.